Ravi Rao
Director/Board Member at DBV TECHNOLOGIES
Net worth: 9 828 $ as of 2024-03-30
Profile
Dr. Ravi M. Rao is a Chief Medical Officer at Swedish Orphan Biovitrum AB and a Member at The Royal College of Physicians. He is on the Board of Directors at DBV Technologies SA. Dr. Rao was previously employed as a Chief Medical Officer by Aeglea Biotherapeutics, Inc. and a Head-Global Medical Affairs by GlaxoSmithKline Plc. He received his undergraduate degree from the University of Cambridge and a doctorate degree from Imperial College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DBV TECHNOLOGIES SA
0.01% | 2023-02-14 | 6,837 ( 0.01% ) | 9 828 $ | 2024-03-30 |
Ravi Rao active positions
| Companies | Position | Start |
|---|---|---|
| DBV TECHNOLOGIES | Director/Board Member | 2021-05-18 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 2024-03-31 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 2022-03-31 |
Former positions of Ravi Rao
| Companies | Position | End |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2021-12-31 |
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-08-09 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 2019-09-30 |
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | - |
Training of Ravi Rao
| Imperial College London | Doctorate Degree |
| University of Cambridge | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Ravi Rao
